Medical Cannabis Market
Report ID: SQMIG35I2169
Report ID: SQMIG35I2169
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35I2169 |
Region:
Global |
Published Date: December, 2025
Pages:
219
|Tables:
63
|Figures:
76
Global Medical Cannabis Market size was valued at USD 22.27 billion in 2024 and is poised to grow from USD 27.1 billion in 2025 to USD 130.42 billion by 2033, growing at a CAGR of 21.7% during the forecast period (2026-2033).
To receive these medicines, patients must have a prescription from a licensed physician or be enrolled in an approved medical trial. However, patients must pay for their medication in full, as medical cannabis is not covered by the Pharmaceutical Benefits Scheme (PBS). Considering the considerable history pertaining to cannabis, there exists today very little official evidence to aid doctors in using it for medical purposes. However, some studies indicate that distinct therapies based on cannabis can alleviate the conditions caused by multiple sclerosis, epilepsy, cancer (such as pain, nausea, anorexia), chronic non cancer pain and some symptoms of palliative care. The Government of the Commonwealth has issued papers on the latest research regarding its benefits for a range of diseases.
Advances in scientific research, shifting societal attitudes, and growing support from medical professionals are all fueling the rapid increase in medical cannabis acceptance. Research provides a solid foundation for the therapeutic use of cannabis by demonstrating their medical benefits in the treatment of multiple sclerosis, anxiety, epilepsy, and chronic pain. This growing body of evidence is influencing public opinion, reducing the stigma associated with cannabis, and promoting broader social acceptance of its therapeutic use. At the same time, as medical cannabis has been shown to improve patient outcomes, more and more doctors are recommending it.
US Medical Cannabis Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2026-2033
Global Market Size
USD 18.3 billion
Largest Segment
Flower
Fastest Growth
Flower
Growth Rate
21.7% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Medical Cannabis Market is segmented by Type of Product, Species, Derivatives, Application, Route of Administration, Distribution Channel and region. Based on Type of Product, the market is segmented into Flower, Concentrates, Edibles, Topicals & Transdermals and Others. Based on Species, the market is segmented into Indica, Sativa and Hybrid. Based on Derivatives, the market is segmented into Tetrahydrocannabinol (THC), Cannabidiol (CBD) and Others. Based on Application, the market is segmented into Chronic Pain Management, Mental Health Management, Neurological Health and Others. Based on Route of Administration, the market is segmented into Inhalation, Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per categorization by product type, the market is classified as flowers, concentrates, and others. Among these, flowers earned the largest share and continues to hold the dominant global medical cannabis market share. With regard to the global medical cannabis market, there is a wide range of product forms available, flowers are one of the most widely accepted form of medicinal cannabis, due to the different ways of administration that it provides such as welding, boiling, or even infusion into edibles or oils. New product development focuses on the high growth strains which are of specific flowers bred for the use in conditions such as chronic pain, anxiety and aggression, epilepsy. Its wide acceptance can be attributed to the fact that it is more affordable than its processed variations for the consumers, its quick availability of effects to the consumers and the consumer's previous experience with it and hence it comes out as the preferred type of medical cannabis for the majority of the medical cannabis consumers.
Concentrates are projected to be the fastest-growing product type in the global medical cannabis market due to their potency, versatility, and precision. Products such as oils, waxes, tinctures, and such like contain a higher concentration of Cannabinoids so that they are effective in the management of chronic pain conditions and epilepsy with lower doses. New technologies for extraction guarantee both quality and uniformity, which satisfies patients looking for potent well controlled medicines. Besides, concentrates enhance other ways of administration such as vaping or sublingual, which fits changing needs of the patients. Concentrates are also gaining acceptance due to people's understanding of their efficacy and ease of use, making them a major growth factor in the global medical cannabis market.
Pain management dominates the global medical cannabis market due to the widespread prevalence of chronic pain conditions and the growing demand for alternative therapies. Medical cannabis is a solution that has emerged naturally, with the help of cannabis derived compounds like THC and CBD that significantly aid in alleviating pain and inflammation as they interact with the endo-cannabinoid system. Developments in this area are shifting towards custom medications for instance accurately adjusted ratios of cannabinoids and other forms of administration like transdermal patches, ingested forms and under the tongue sprays to optimize the treatment and the patients' experience. Due to the increasing fears of opioid addiction, cannabis for medical purposes is gaining ground especially for pain control reinforcing its dominance in this domain by offering a non-therapeutic addictive drug.
Mental health management is poised to be the fastest-growing segment in the global medical cannabis market due to increasing recognition of its potential in treating anxiety, depression, PTSD, and insomnia. Cannabinoids are a class of molecules that can help reduce anxiety and depression; thus, they present a natural solution that is less or not at all invasive than psychotropics. There are improvements in strain development and accuracy of dosing through the use of oils, capsules and edibles among others that yield better results. Improved awareness about mental health issues and the stigma around the use of cannabis also contribute to the adoption of the treatment. Due to patients' needs for non-dependency forming treatment methods, which are safe, medical cannabis is oh so revolutionizing the psychiatric field, giving rise to immense expansion.
Effects of the drug on a number of health issues.
To get detailed segments analysis, Request a Free Sample Report
North America dominates the global medical cannabis market due to progressive legalization, robust healthcare infrastructure, and a well-established cannabis industry in countries like the U.S. and Canada. It is evident that the presence of enabling regulations such as medical cannabis legalization and decriminalization has positively influenced the market. There is a high public awareness, sophisticated cultivation techniques, and more resources deployed in the region towards R&D for the cause of their leadership. Also, there is a high occurrence of chronic diseases, mental health issues and the need for pain management that has created a demand. North America is also at the center of the evolution of the global medical cannabis industry, assisted by the market ecosystems that inform its developments.
Europe is the fastest-growing region in the global medical cannabis market due to progressive legalization and increasing acceptance of cannabis-based therapies. As nations such as Germany, the U.K., and Italy, for instance, slow down to learn how to reform patient-centric regulatory frameworks or implement government-sponsored health care reimbursement measures, the adoption of medical cannabis is propelled by the persistent aversion towards some medical conditions, pain in particular, wherein it is promoted as a remedy, chronic irritations such as pain, management of epilepsy and mental health issues. Furthermore, the construction of growing and processing plants and the emphasis on GMP-grade products contribute to growth. The region's focus on the research and clinical application of medical cannabis in the health care system, makes the medical cannabis market in European region vibrant and poised for growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Regulatory Advancements in Regions
Rising Chronic Disease Prevalence
Limited Clinical Evidence
Stigma and Public Perception
Request Free Customization of this report to help us to meet your business objectives.
The global medical cannabis market is fierce and has a lot of innovations as well as players who are taking more market share. Major firms include Aurora Cannabis, Canopy Growth, Tilray, and Cronos Group, which have a cultivation, product development, and distribution of medical goods related to cannabis. These firms are committing resources to undertake clinical studies, expand globally, and enter strategic alliances. Also, this is a fast-changing market and apart from the key players, the competition is becoming more intense with the entry of new players and expansion of regional players.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, in conclusion, the global medical cannabis industry is poised for continued growth, driven by increasing research, regulatory advancements, and expanding therapeutic applications. While the demand for pain management and mental health treatments continues to rise, regions like North America and Europe are leading the charge, due to favorable legal frameworks and healthcare systems.
Despite challenges, such as limited clinical evidence and stigma, the market's potential remains strong, with new product innovations and strategic partnerships. Enhancements are made in terms of accessibility and effectiveness of medical cannabis, ensuring its integration into mainstream healthcare systems globally.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 22.27 billion |
| Market size value in 2033 | USD 130.42 billion |
| Growth Rate | 21.7% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Medical Cannabis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Medical Cannabis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Medical Cannabis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Medical Cannabis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Medical Cannabis Market size was valued at USD 22.27 Billion in 2024 and is poised to grow from USD 27.1 Billion in 2025 to USD 130.42 Billion by 2033, growing at a CAGR of 21.7% during the forecast period (2026–2033).
The global medical cannabis market is fierce and has a lot of innovations as well as players who are taking more market share. Major firms include Aurora Cannabis, Canopy Growth, Tilray, and Cronos Group, which have a cultivation, product development, and distribution of medical goods related to cannabis. These firms are committing resources to undertake clinical studies, expand globally, and enter strategic alliances. Also, this is a fast-changing market and apart from the key players, the competition is becoming more intense with the entry of new players and expansion of regional players. 'Curaleaf Holdings, Inc. (USA) ', 'Trulieve Cannabis Corp. (Canada) ', 'Green Thumb Industries Inc. (GTI) (USA) ', 'Cresco Labs Inc. (USA) ', 'Canopy Growth Corporation (Canada) ', 'Aurora Cannabis Inc. (Canada) ', 'Tilray Brands, Inc. (USA) ', 'Jazz Pharmaceuticals plc (Ireland) ', 'Medical Marijuana, Inc. (USA) ', 'Organigram Holdings Inc. (Canada) ', 'Cronos Group Inc. (Canada) ', 'TerrAscend Corp. (Canada) ', 'Verano Holdings Corp. (Canada) ', 'Aleafia Health Inc. (Canada) ', 'Indiva Limited (Canada) ', 'MediPharm Labs Corp. (Canada) ', 'Charlotte's Web Holdings, Inc. (USA)'
The growth of the global medical cannabis market is largely on account of the regulatory changes, with several more countries allowing the use of medical cannabis for treatment purposes. However, more welcoming policies such as allowing the introduction of cannabis products into the market, providing standard procedures for growing and distributing them, establishes ready market conditions that enhance increased patient access and product development.
Increasing Adoption of Cannabis for Mental Health Treatment: One key trend in the global medical cannabis market is the growing use of cannabis for mental health treatment. Cannabis for medical purposes is gaining popularity as a better option to patients seeking other therapeutic interventions as the benefits in minimizing anxiety, depression and post-traumatic stress disorders are coming to light.
North America dominates the global medical cannabis market due to progressive legalization, robust healthcare infrastructure, and a well-established cannabis industry in countries like the U.S. and Canada. It is evident that the presence of enabling regulations such as medical cannabis legalization and decriminalization has positively influenced the market. There is a high public awareness, sophisticated cultivation techniques, and more resources deployed in the region towards R&D for the cause of their leadership. Also, there is a high occurrence of chronic diseases, mental health issues and the need for pain management that has created a demand. North America is also at the center of the evolution of the global medical cannabis industry, assisted by the market ecosystems that inform its developments.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
